Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域：
Metabolic Disease; Inflammation/Immunology
Target：
IC50: 4.8 μM (BSEP); 6.2 μM (MRP4); 7.5 μM (MDR3)
描述：
BMS-986020 sodium is a high-affinity LPA1 antagonist, inhibits bile acid and phospholipid transporters with IC50s of 4.8 μM, 6.2 μM, and 7.5 μM for BSEP, MRP4, and MDR3, respectively.
m.cnreagent.com
